CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

CA Cancer J Clin 1993; 43:263
doi: 10.3322/canjclin.43.5.263
© 1993 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laws, E. R.
Right arrow Articles by Thapar, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laws, E. R., Jr
Right arrow Articles by Thapar, K.

CA: A Cancer Journal for Clinicians, Vol 43, Issue 5 263-271, Copyright © 1993 by American Cancer Society

ARTICLES

Brain tumors

E. R. Laws Jr and K. Thapar
University of Virginia, Charlottesville.

Brain tumors are a relatively common cancer in all age groups, and the incidence of both primary and metastatic brain tumors is increasing. Fortunately, dramatic advances in methods of diagnosis, surgical technique, and adjuvant therapy have all contributed to an improved outlook for patients with brain tumors. This article reviews the classification, symptoms, diagnosis, and treatment of brain tumors.


This article has been cited by other articles:


Home page
 Ann OncolHome page
E. Raymond, M. Fabbro, V. Boige, O. Rixe, M. Frenay, G. Vassal, S. Faivre, E. Sicard, C. Germa, J. M. Rodier, et al.
Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naive patients with glioblastoma
Ann. Onc., April 1, 2003; 14(4): 603 - 614.
[Abstract] [Full Text] [PDF]

Home page
 ptjournalHome page
C. I Hill, C. S Nixon, J. L Ruehmeier, and L. M Wolf
Brain Tumors
Physical Therapy, May 1, 2002; 82(5): 496 - 502.
[Full Text] [PDF]

Home page
 Neuro OncolHome page
R. O. Dillman, W. M. Shea, D. F. Tai, K. Mahdavi, N. M. Barth, B. R. Kharkar, M. M. Poor, C. K. Church, and C. DePriest
Interferon-{alpha}2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma
Neuro-oncol, January 1, 2001; 3(1): 35 - 41.
[Abstract] [PDF]

Home page
 Clin. Cancer Res.Home page
C. Malone, P. M. Schiltz, S. K. Nayak, M. W. Shea, and R. O. Dillman
Combination Interferon-{{alpha}}2a and 13-cis-Retinoic Acid Enhances Radiosensitization of Human Malignant Glioma Cells in Vitro
Clin. Cancer Res., February 1, 1999; 5(2): 417 - 423.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by American Cancer Society.